Clinical Trial Update: Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the efficacy and safety of baricitinib for pulmonary injury that occurs after intracerebral hemorrhage, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Injury After Intracerebral Hemorrhage

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Pulmonary Injury After Intracerebral Hemorrhage | Phase 1, Phase 2 | Status: RECRUITING